Tuesday, June 14, 2022

Chimeric (ASX:CHM) hits new milestone: viral vector manufactured for clinical program

A viral vector is considered as the backbone of CAR T cell therapy production as it holds the instructions of genetic engineering.
https://www.google.com/url?rct=j&sa=t&url=https://kalkinemedia.com/au/sponsored/chimeric-asxchm-hits-new-milestone-viral-vector-manufactured-for-clinical-program&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AOvVaw0SAdrbBcZWx3vCI836B-6h

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...